AstraZeneca PLC Ordinary Shares · Change in Working Capital

Latest reported-$1.83Bperiod endingJun 30, 2026

AZN Change in Working Capital ($46.29M → -$1.83B)

Annual change in working capital

High-resolution chart · PNG

AZN change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Change in Working Capital — Annual fiscal periods (USD)
Period ending	Change in Working Capital (USD)
Dec 31, 2025	-1,162,287,000
Dec 31, 2024	-893,000,000
Dec 31, 2023	300,000,000
Dec 31, 2022	3,757,000,000
Dec 31, 2021	2,021,000,000
Dec 31, 2020	361,000,000
Dec 31, 2019	-346,000,000
Dec 31, 2018	-639,000,000
Dec 31, 2017	-50,000,000
Dec 31, 2016	926,000,000
Dec 31, 2015	-49,000,000
Dec 31, 2014	2,508,000,000
Dec 31, 2013	166,000,000
Dec 31, 2012	-706,000,000
Dec 31, 2011	-897,000,000
Dec 31, 2010	82,000,000
Dec 31, 2009	1,329,000,000
Dec 31, 2008	-210,000,000
Dec 31, 2007	-443,000,000
Dec 31, 2006	108,000,000
Dec 31, 2005	332,000,000
Dec 31, 2004	-67,000,000
Dec 31, 2003	-1,101,000,000
Dec 31, 2002	305,151,002
Dec 31, 2001	-1,372,960,086
Dec 31, 2000	-280,798,184
Dec 31, 1999	-147,926,103
Dec 31, 1998	-11,619,222
Dec 31, 1997	-89,268,002
Dec 31, 1996	-200,363,051
Dec 31, 1995	-63,353,730
Dec 31, 1994	-50,028,923
Dec 31, 1993	102,064,966
Dec 31, 1992	15,166,911
Dec 31, 1991	-136,596,684
Dec 31, 1990	46,294,510